StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
CALA opened at $0.01 on Thursday. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.12.
About Calithera Biosciences
See Also
- Five stocks we like better than Calithera Biosciences
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- Do ETFs Pay Dividends? What You Need to Know
- AppLovin: Can Record Profits Overcome Market Skepticism?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- MarketBeat Week in Review – 04/14 – 04/18
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
